Israeli AI startup forges $18m partnership with Astra Zeneca for cancer drug trials
The Times of Israel Last year, Cyto Reason, an Israeli startup that uses AI to develop computational disease models for drug discovery, secured investment from pharma …
Read the original at timesofisrael.com ↗
- Topics
- Healthcare
- Mentions
- Israel
- Tags
- AI Use Case
- Tracked via
- Google Alert “that uses AI to”